BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15780061)

  • 1. Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.
    Deltenre P; Mathurin P; Dharancy S; Moreau R; Bulois P; Henrion J; Pruvot FR; Ernst O; Paris JC; Lebrec D
    Liver Int; 2005 Apr; 25(2):349-56. PubMed ID: 15780061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
    Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
    United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.
    Salerno F; Cammà C; Enea M; Rössle M; Wong F
    Gastroenterology; 2007 Sep; 133(3):825-34. PubMed ID: 17678653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
    Russo MW; Sood A; Jacobson IM; Brown RS
    Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic use of transjugular intrahepatic portosystemic shunt aids in the treatment of refractory ascites: metaregression and trial sequential meta-analysis.
    Chen RP; Zhu Ge XJ; Huang ZM; Ye XH; Hu CY; Lu GR; Lu DY; Phemba IL
    J Clin Gastroenterol; 2014 Mar; 48(3):290-9. PubMed ID: 24030734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.
    Garcia-Tsao G
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):380-9. PubMed ID: 16819501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis.
    Bai M; Qi XS; Yang ZP; Yang M; Fan DM; Han GH
    World J Gastroenterol; 2014 Mar; 20(10):2704-14. PubMed ID: 24627607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial.
    Narahara Y; Kanazawa H; Fukuda T; Matsushita Y; Harimoto H; Kidokoro H; Katakura T; Atsukawa M; Taki Y; Kimura Y; Nakatsuka K; Sakamoto C
    J Gastroenterol; 2011 Jan; 46(1):78-85. PubMed ID: 20632194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
    Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Transjugular Intrahepatic Portosystemic Shunt versus Large-Volume Paracentesis in Refractory Ascites: Results of a Markov Model Incorporating Individual Patient-Level Meta-Analysis and Nationally Representative Cost Data.
    Kwan SW; Allison SK; Gold LS; Shin DS
    J Vasc Interv Radiol; 2018 Dec; 29(12):1705-1712. PubMed ID: 30392803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites.
    Williams DB; Waugh R; Selby W
    Aust N Z J Med; 1998 Oct; 28(5):620-6. PubMed ID: 9847951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIPS for management of refractory ascites: response and survival are both unpredictable.
    Thuluvath PJ; Bal JS; Mitchell S; Lund G; Venbrux A
    Dig Dis Sci; 2003 Mar; 48(3):542-50. PubMed ID: 12757168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution.
    Martinet JP; Fenyves D; Legault L; Roy L; Dufresne MP; Spahr L; Lafortune M; Pomier-Layrargues G
    Dig Dis Sci; 1997 Jan; 42(1):161-6. PubMed ID: 9009133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An experience with covered transjugular intrahepatic portosystemic shunt for refractory ascites from western India.
    Amarapurkar DN; Punamiya S; Patel ND
    Ann Hepatol; 2006; 5(2):103-8. PubMed ID: 16807516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIPS for refractory ascites: a single-centre experience.
    Thalheimer U; Leandro G; Samonakis DN; Triantos CK; Senzolo M; Fung K; Davies N; Patch D; Burroughs AK
    J Gastroenterol; 2009; 44(10):1089-95. PubMed ID: 19572096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Increased Mortality After TIPS Compared with Serial Large Volume Paracenteses in Patients with Higher Model for End-Stage Liver Disease Score and Refractory Ascites.
    Ronald J; Rao R; Choi SS; Kappus M; Martin JG; Sag AA; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY
    Cardiovasc Intervent Radiol; 2019 May; 42(5):720-728. PubMed ID: 30603968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transjugular intrahepatic portosystemic shunt for refractory ascites: results in 50 patients].
    Kanazawa H; Narahara Y; Fukuda T; Kondo C; Harimoto H; Matsushita Y; Kidokoro H; Katakura T; Atsukawa M; Taki Y; Kimura Y; Osada Y; Nakatsuka K; Sakamoto C
    Nihon Shokakibyo Gakkai Zasshi; 2009 Mar; 106(3):356-69. PubMed ID: 19262049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.